Blood Glucose Management in Intensive Care Units

Survey of Practices on the Management of Glycemia in Patients Hospitalized in Intensive Care Units

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05775770

Acronym

GINGER

Enrollment

525

Registered

2023-03-20

Start date

2023-03-20

Completion date

2024-03-12

Last updated

2023-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glucose Test Site Bleeding, Hyperglycemia, Insulin Hypoglycemia

Keywords

glucose control, insulin

Brief summary

The investigators propose to conduct a study of practices to describe the methods of managing glycemic control in hospitalized patients in critical care. This is a prospective multicenter observational study conducted in Intensive Medicine and Resuscitation departments in France and Belgium. The aim of this study is to carry out an inventory of the current practices of glycemia management as well as their modalities. Being one of the key points of the management, this work will have for main objective to raise the importance of the glycemic variabilities according to the methods of insulin therapies used.

Interventions

DRUGInsulin

insulin therapy

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient with hyperglycaemia requiring an insulin prescription within 48 hours of admission * Insulin therapy started less than 12 hours before inclusion of the patient in the study * Expected duration of hospitalization greater than or equal to 48 hours

Exclusion criteria

* Moribund patients * Patients admitted for ketoacidosis or hyperosmolar coma * Patients admitted for symptomatic hypoglycaemia * Patient requiring insulin for serum potassium correction * Severe acute hepatocellular insufficiency * Age \< 18 years old * Pregnant or breastfeeding women * Patients under legal protection measures

Design outcomes

Primary

Measure	Time frame	Description
glycemic variability	48 hours	Study the impact of glycemic management protocols on the glycemic variability of patients hospitalized in intensive care

Secondary

Measure	Time frame	Description
adverse outcomes	48 hours	incidence of hypoglycaemia
Analysis of nursing workload	48 hours	nurse / patient ratio

Countries

France

Contacts

Primary ContactSuzanne Goursaud

goursaud-s@chu-caen.fr1 45 86 74 00

Backup ContactLaurent Poiroux

LaPoiroux@chu-angers.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026